CIK: 1855608 - Address: C/O Bridgebio Pharma, Inc., 3160 Porter Dr., Suite 250, Palo Alto, CA 94304
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/20/24 16:03
2/15/24
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsValantine HannahCADM.d258.45031285D
2/20/24 16:03
2/15/24
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsValantine HannahCADS.d-11037.750-3-365D
2/13/24 16:00
12/28/21
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsValantine HannahCADP4412.9603New3I
1/18/24 16:10
1/16/24
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsValantine HannahCADM.d258.45032D
1/18/24 16:10
1/16/24
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsValantine HannahCADS.d-11137.970-3-622D
12/19/23 16:00
12/15/23
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsValantine HannahCADM.d258.45032D
12/19/23 16:00
12/15/23
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsValantine HannahCADS.d-10536.120-3-622D
11/17/23 16:09
11/15/23
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsValantine HannahCADM.d258.45032D
11/17/23 16:09
11/15/23
BBIOBridgebio Pharma, Inc.DEHealthDrugPharmaceutical PreparationsValantine HannahCADS.d-8730.000-3-622D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact